GL1X · GenesisL1 explorer

MolNFT v1 · #182097 · protein

Improved ligand discovery using micro-beam data collection at the edge of protein crystals

7MGU · Endo-1,4-beta-xylanase: “Improved ligand discovery using micro-beam data collection at the edge of protein crystals”. X-ray diffraction, 2 ligands (ARG, NA), 1 pocket (best druggability 0.50). MolNFT v1 #182097 on GenesisL1: 3D…

PDB
7MGU
Type
protein
Length
190 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Endo-1,4-beta-xylanase
EC
3.2.1.8
UniProt
B2CZF9
Ligands
ARG, NA
Pockets
1 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 5% helix, 62% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEndo-1,4-beta-xylanase (EC 3.2.1.8)protein1905% helix, 62% strandB2CZF9

Ligands and binding sites

  • ARG · Arginine · ligand · chains A
  • NA · Sodium ion · metal · 5 copies · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12010.500.7632ARG

Modifications

Observed in the structure: 1 modified (cyclization).

Compared structures

  • 7MGU · Improved ligand discovery using micro-beam data collection at the edge of protein crystals · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.